Patents by Inventor Michael H. Arenberg

Michael H. Arenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200000791
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: May 7, 2019
    Publication date: January 2, 2020
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Patent number: 10328068
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: June 25, 2019
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20180214435
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 2, 2018
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Patent number: 9884056
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: February 6, 2018
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20170252330
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: February 16, 2017
    Publication date: September 7, 2017
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Patent number: 9616055
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: April 11, 2017
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20160058746
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: July 2, 2015
    Publication date: March 3, 2016
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20140011842
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 9, 2014
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Patent number: 8197461
    Abstract: A specialized drug delivery unit for inner ear treatment which employs a portion of carrier media material containing one or more therapeutic agents therein. The carrier media material is designed to release the therapeutic agents in a controlled manner over time. The drug delivery unit is sized for placement in the round window niche of a patient. The released therapeutic agents come in contact with the round window membrane and pass therethrough into the inner ear for treatment purposes. This system provides many benefits ranging from the ability to deliver drugs in a site specific, highly controlled manner to the transfer of such materials with minimal patient discomfort and monitoring requirements.
    Type: Grant
    Filed: December 4, 1998
    Date of Patent: June 12, 2012
    Assignee: Durect Corporation
    Inventors: Irving K. Arenberg, Michael H. Arenberg, Christine Lemke, John A. Berglund
  • Publication number: 20100260844
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 14, 2010
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20040172005
    Abstract: The present invention provides devices and methods for delivery of very low dosages to the inner ear. The device is a self-contained unit that reproducibly and consistently delivers a dose of therapeutic agent that is effective, yet below the ototoxic threshold for that agent. The invention further provides therapeutic methods using the device of the invention.
    Type: Application
    Filed: December 18, 2003
    Publication date: September 2, 2004
    Inventors: Michael H. Arenberg, Charles Rampersaud, Edward M. Gillis, Su Il Yum, Felix Theeuwes
  • Patent number: 6685697
    Abstract: The present invention provides methods and devices for controlled delivery of a therapeutic agent to an internal cavity of the ear, particularly to the inner ear. In general, the invention uses a drug delivery unit for inner ear treatment which employs a portion of carrier media material containing one or more therapeutic agents therein. The carrier media material is designed to release the therapeutic agents in a controlled manner over time. The drug delivery unit is shaped and sized for placement of at least a portion thereof in the round window niche of a patient. The released therapeutic agents come in contact with the round window membrane and pass therethrough into the inner ear for treatment purposes. This system provides many benefits ranging from the ability to deliver drugs in a site specific, highly controlled manner to the transfer of such materials with minimal patient discomfort and monitoring requirements.
    Type: Grant
    Filed: September 25, 2001
    Date of Patent: February 3, 2004
    Assignee: Durect Corporation
    Inventors: Irving K. Arenberg, Michael H. Arenberg, Christine Lemke, John A. Berglund
  • Patent number: 6648873
    Abstract: Methods and apparatus used for securing the end of a drug-delivery catheter at the round window niche of the inner ear; specifically an apparatus employing a miniature threaded screw pump to inflate a balloon allowing a catheter to be secured within the round window niche of the inner ear.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: November 18, 2003
    Assignee: Durect Corp.
    Inventors: Michael H. Arenberg, Edward M. Gillis, Charles R. Rampersaud
  • Publication number: 20030060799
    Abstract: Methods and apparatus used for securing the end of a drug-delivery catheter at the round window niche of the inner ear; specifically an apparatus employing a miniature threaded screw pump to inflate a balloon allowing a catheter to be secured within the round window niche of the inner ear.
    Type: Application
    Filed: September 21, 2001
    Publication date: March 27, 2003
    Inventors: Michael H. Arenberg, Edward M. Gillis, Charles R. Rampersaud
  • Patent number: 6440102
    Abstract: An apparatus for delivering fluid materials into and out of the inner ear via the round window membrane. A fluid transfer conduit is provided which includes one or more passageways therethrough which may have a semipermeable membrane associated therewith to control fluid flow. Attached to the conduit is an inflatable bladder sized for insertion within the round window niche. When inflated, the bladder engages the internal side wall of the niche, thereby securing the bladder and part of the conduit within the niche. The conduit can then transfer fluids to and from the niche and the fluid-permeable round window membrane therein. Bladder inflation may be achieved through one of the passageways within the conduit which can deliver an inflation fluid into the bladder. Also, the conduit may include an elongate conductive diagnostic member for transferring electrical potentials to and from the inner ear.
    Type: Grant
    Filed: July 23, 1998
    Date of Patent: August 27, 2002
    Assignee: Durect Corporation
    Inventors: Irving K. Arenberg, Michael H. Arenberg
  • Patent number: 6045528
    Abstract: An apparatus for transferring fluids into and out of the inner ear through the round window membrane. The apparatus includes a cover member sized for placement over the round window niche. Fluid delivery and fluid extraction conduits are provided which are operatively connected to the cover member so that fluids can pass therethrough. The cover member is positioned over the niche to create a fluid-recieving zone between the cover member and the round window membrane. As a result, fluids can be delivered into or withdrawn from the zone. Alternatively, a single conduit may be used for fluid delivery and extraction. Another variation uses a compressible cover member positioned within the round window niche to form a fluid-receiving zone between the cover member and the round window membrane. The same type of conduit system described above is attached to the compressible cover member.
    Type: Grant
    Filed: June 13, 1997
    Date of Patent: April 4, 2000
    Assignee: IntraEar, Inc.
    Inventors: Irving K. Arenberg, Michael H. Arenberg